Effect of osteocalcin on sarcopenic obesity
Project/Area Number |
18K09521
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Review Section |
Basic Section 57010:Oral biological science-related
|
Research Institution | Kyushu University |
Principal Investigator |
|
Project Period (FY) |
2018-04-01 – 2022-03-31
|
Project Status |
Completed (Fiscal Year 2021)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Keywords | オステオカルシン / 脂肪分解 / 肥満 / 酸化ストレス / インスリン抵抗生 / 骨格筋 / サルコペニア肥満 / インスリン抵抗性 / サルコペニア |
Outline of Final Research Achievements |
Uncarboxylated osteocalcin (GluOC) is a bone-derived hormone that plays an important role not only in glucose and energy metabolism but also in maintaining skeletal muscle mass. GPRC6A, a member of family C of G protein-coupled receptors, has been reported to serve as a GluOC receptor. We analyzed adipocyte-specific GPRC6A deficient mice and found that these animals manifested adipocyte hypertrophy under obesogenic environment. This was associated with reduced lipolytic activity due to down-regulation of lipolytic enzymes in adipose tissue of the knockout mice. Suppressed lipolysis resulted in reduced fatty acid release in the circulation compared with control mice. Our results suggest that the constitutive activation of GPRC6A signaling by GluOC in adipocytes plays a key role in lipolysis, providing fatty acid as an energy source to the skeletal muscle.
|
Academic Significance and Societal Importance of the Research Achievements |
サルコペニア肥満は、代謝異常と運動機能低下の悪循環によって、サルコペニアや肥満の単独事象よりも深刻な身体機能低下をもたらし、要介護・寝たきりのリスクが高まる。GluOCは、脂肪細胞におけるGPRC6Aシグナルを介して脂肪の分解を促進する。つまり、GluOCは食餌誘発性の肥満とそれに起因する代謝異常を抑制するのみならず、脂肪分解促進作用による遊離脂肪酸放出によって骨格筋にエネルギー源を供給し、骨格筋の機能向上にも寄与する。GluOCはサルコペニアと肥満の両方にアプローチすることでサルコペニア肥満の悪循環を断ち切る治療標的となり得る。
|
Report
(5 results)
Research Products
(19 results)
-
[Journal Article] Phospholipase C-related but catalytically inactive protein acts as a positive regulator of insulin signalling in adipocytes.2022
Author(s)
Gao, J., Mizokami, A., Takeuchi, H., Li, A., Huang, F., Nagano, H., Kanematsu, T., Jimi, E., Hirata, M.
-
Journal Title
J. Cell. Sci.
Volume: 135
Issue: 1
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
-
-
-
[Journal Article] GLP-1 signaling is required for improvement of glucose tolerance by osteocalcin. J. Endocrinol.2020
Author(s)
Mizokami, A., Mukai, S., Gao, J., Kawakubo-Yasukochi, T., Otani, T., Takeuchi, H., Jimi, E., Hirata, M.
-
Journal Title
Journal of Endocrinology
Volume: 244
Issue: 2
Pages: 285-296
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
[Journal Article] Osteocalcin triggers Fas/FasL-mediated necroptosis in adipocytes regulated by the activation of p300.2018
Author(s)
Otani, T., Matsuda, M., Mizokami, A., Kitagawa, N., Takeuchi, H., Jimi, E.,Inai, T., and Hirata, M.
-
Journal Title
Cell Death Disease
Volume: 9
Issue: 12
Pages: 1194-1210
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-